Tempus AI (TEM) Projected to Post Quarterly Earnings on Monday

Tempus AI (NASDAQ:TEM) is anticipated to post its quarterly earnings results after the market closes on Monday, February 24th. Analysts expect Tempus AI to post earnings of ($0.15) per share and revenue of $202.80 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Tempus AI Price Performance

Shares of TEM opened at $68.09 on Friday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business’s fifty day simple moving average is $50.29 and its two-hundred day simple moving average is $51.72.

Insider Activity at Tempus AI

In other Tempus AI news, CAO Ryan M. Bartolucci sold 13,770 shares of the firm’s stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares of the company’s stock, valued at $3,434,220. This trade represents a 19.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jennifer A. Doudna sold 1,320 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $90.00, for a total value of $118,800.00. Following the sale, the director now directly owns 36,011 shares in the company, valued at approximately $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,583,467 shares of company stock worth $130,542,311.

Wall Street Analysts Forecast Growth

TEM has been the topic of a number of research reports. TD Cowen restated a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and raised their price target for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Loop Capital dropped their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. William Blair downgraded Tempus AI from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Finally, Needham & Company LLC restated a “buy” rating and issued a $56.00 price target on shares of Tempus AI in a research note on Tuesday, January 14th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $58.55.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.